Literature DB >> 4604455

Evidence for a stable intermediate in leukemia virus activation in AKR mouse embryo cells.

J N Ihle, F T Kenney, R W Tennant.   

Abstract

Analysis of the requirement for serum in the activation of the endogenous leukemia virus expression in AKR mouse embryo cells by 5-iododeoxyuridine shows that activation can be dissociated into two discrete serum-dependent events. The first involves incorporation of 5-iododeoxyuridine into DNA and results in the formation of a stable "activation intermediate" resembling the provirus formed during infection of stationary mouse embryo cells with exogenous leukemia virus. The second event, resulting in expression of the activation intermediate as synthesis of virus proteins, requires DNA replication but not 5-iododeoxyuridine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604455      PMCID: PMC355537     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus.

Authors:  W P Rowe; J W Hartley; M R Lander; W E Pugh; N Teich
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  Messenger and heterogeneous nuclear RNA in HeLa cells: differential inhibition by cordycepin.

Authors:  S Penman; M Rosbash; M Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

5.  Inhibition of the DNA polymerase of Rauscher leukemia virus by single-stranded polyribonucleotides.

Authors:  F W Tuominen; F T Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

6.  Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  D R Lowy; W P Rowe; N Teich; J W Hartley
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

Review 7.  Some implications of the activation of murine leukemia virus by halogenated pyrimidines.

Authors:  W P Rowe; D R Lowy; N Teich; J W Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

8.  Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells.

Authors:  S A Aaronson; G J Todaro; E M Scolnick
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

9.  Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA.

Authors:  J E Darnell; L Philipson; R Wall; M Adesnik
Journal:  Science       Date:  1971-10-29       Impact factor: 47.728

10.  Genetic factors influencing C-type RNA virus induction.

Authors:  J R Stephenson; S A Aaronson
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  4 in total

1.  Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses.

Authors:  E F Fritsch; H M Temin
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

2.  Transposition of the yeast retroviruslike element Ty3 is dependent on the cell cycle.

Authors:  T M Menees; S B Sandmeyer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

3.  Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts.

Authors:  R W Tennant; B Schluter; W Yang; A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

4.  Genetic evidence for a product of the Fv-1 locus that transfers resistance to mouse leukemia viruses.

Authors:  R W Tennant; B Schluter; F E Myer; J A Otten; W K Yang; A Brown
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.